BioHarvest Sciences Inc.
OTC: CNVCF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ilan Sobel
- Headquarters
- Vancouver, Canada
- IPO year
- 2021
- Market cap
- $109.2M
- Website
- https://www.bioharvest.com
Loading CNVCF…
Loading profile data…Frequently asked questions about CNVCF
What does BioHarvest Sciences Inc. (CNVCF) do?
BioHarvest Sciences Inc., along with its subsidiaries, supplies a range of nutraceutical products and medical cannabis to customers both in Israel and globally. The company leverages an innovative plant cell growth technology that allows it to cultivate active secondary metabolites directly from cells, completely circumventing the need to grow t...
Where does CNVCF trade?
BioHarvest Sciences Inc. (CNVCF) trades on the Other OTC.
What sector is CNVCF in?
BioHarvest Sciences Inc. (CNVCF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of BioHarvest Sciences Inc.?
Ilan Sobel is the chief executive officer of BioHarvest Sciences Inc. (CNVCF).
Where is BioHarvest Sciences Inc. headquartered?
BioHarvest Sciences Inc. is headquartered in Canada.
Does CNVCF pay a dividend?
BioHarvest Sciences Inc. (CNVCF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CNVCF go public?
BioHarvest Sciences Inc. (CNVCF) completed its initial public offering in 2021.